Beyondbmi, a Dublin, Ireland-based medically-led digital obesity clinic, raised €1M in Seed funding.
The round was led by private investors and Enterprise Ireland, with participation from existing investors including Mick Slein (Chairman of Robus), David O’Reilly, Paddy Dillion (Head of Corporate Finance in Grant Thornton), Bill Walsh, John Purdy (Chairman of Ergo and Beyondbmi), among others. This brings to just over €1.5M the total raised by the University College Dublin (UCD) spin-out company this year.
The company intends to use the funds to invest in its mobile app, to provide clients with more convenient access to their personalised obesity care plans and a supportive community, to hire additional staff to scale its B2B offering, and to expand its expert clinician team. Beyondbmi will expand its services into UK market in 2024.
A UCD School of Medicine spin-out founded by medical doctor Dr Harriet Treacy and product designer Peter Lumley with support from senior team members including world-leading obesity scientists and clinicians, Professor Carel Le Roux and Dr Werd Al-Najim, UCD School of Medicine and UCD Conway Institute and Professor Alex Miras, Ulster University, Beyondbmi combines doctor-prescribed anti-obesity medication with nutritional therapy and one-to-one accountability coaching to deliver health gains through the biology of weight loss. Its approach to addresses obesity through personalised medical interventions, community support, and technology.
FinSMEs
05/12/2023